Long-Term Study Following Patients With Different Types of Porphyria to Understand Disease Progression and Treatment Outcomes

What this Trial Is About

This research aims to study a group of rare metabolic diseases called porphyrias, which can appear in childhood or adulthood due to enzyme deficiencies affecting heme production. These diseases often cause acute neurological attacks or skin sensitivity to light. Because diagnosis is often delayed and the natural course of these diseases is not well understood, the study seeks to better understand disease progression, complications, pregnancy outcomes, and mortality, as well as the effects of current treatments and the development of new therapies. The study includes patients with confirmed diagnoses of various types of porphyrias, such as Acute Intermittent Porphyria, Hereditary Coproporphyria, Variegate Porphyria, and others. It is a long-term observational study conducted by a consortium of academic centers funded by the NIH. Participants are grouped based on their specific porphyria diagnosis and will be followed over time to collect clinical, biochemical, and genetic data. Participants will provide information through clinical evaluations and laboratory tests, including biochemical and genetic studies, at baseline and throughout the study. Researchers will assess disease severity, biomarkers, and treatment effectiveness and tolerability. The study monitors participants over an extended period to gather detailed information about the natural history and outcomes associated with porphyrias. This may include gathering data on complications and pregnancy outcomes. The total participation duration varies by individual.

Longitudinal Study of the Porphyrias